186 related articles for article (PubMed ID: 16189273)
21. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
[TBL] [Abstract][Full Text] [Related]
22. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.
Tjwa M; Luttun A; Autiero M; Carmeliet P
Cell Tissue Res; 2003 Oct; 314(1):5-14. PubMed ID: 13680354
[TBL] [Abstract][Full Text] [Related]
23. Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.
Sands M; Howell K; Costello CM; McLoughlin P
Respir Res; 2011 Jan; 12(1):17. PubMed ID: 21266048
[TBL] [Abstract][Full Text] [Related]
24. PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.
Incio J; Tam J; Rahbari NN; Suboj P; McManus DT; Chin SM; Vardam TD; Batista A; Babykutty S; Jung K; Khachatryan A; Hato T; Ligibel JA; Krop IE; Puchner SB; Schlett CL; Hoffmman U; Ancukiewicz M; Shibuya M; Carmeliet P; Soares R; Duda DG; Jain RK; Fukumura D
Clin Cancer Res; 2016 Jun; 22(12):2993-3004. PubMed ID: 26861455
[TBL] [Abstract][Full Text] [Related]
25. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
Shih SC; Ju M; Liu N; Smith LE
J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
27. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
28. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
Nozaki M; Sakurai E; Raisler BJ; Baffi JZ; Witta J; Ogura Y; Brekken RA; Sage EH; Ambati BK; Ambati J
J Clin Invest; 2006 Feb; 116(2):422-9. PubMed ID: 16453023
[TBL] [Abstract][Full Text] [Related]
29. Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas.
Jiang H; Wu X; Wang H; Huang C; Zhang L
Cell Physiol Biochem; 2015; 36(3):930-6. PubMed ID: 26088746
[TBL] [Abstract][Full Text] [Related]
30. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion.
Babiak A; Schumm AM; Wangler C; Loukas M; Wu J; Dombrowski S; Matuschek C; Kotzerke J; Dehio C; Waltenberger J
Cardiovasc Res; 2004 Mar; 61(4):789-95. PubMed ID: 14985076
[TBL] [Abstract][Full Text] [Related]
31. Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide.
Dhar-Mascareno M; Mascareno E; Golde DW
J Vasc Res; 2009; 46(6):601-8. PubMed ID: 19571580
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
[TBL] [Abstract][Full Text] [Related]
33. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.
Papadopoulos N; Martin J; Ruan Q; Rafique A; Rosconi MP; Shi E; Pyles EA; Yancopoulos GD; Stahl N; Wiegand SJ
Angiogenesis; 2012 Jun; 15(2):171-85. PubMed ID: 22302382
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
Iyer S; Scotney PD; Nash AD; Ravi Acharya K
J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
[TBL] [Abstract][Full Text] [Related]
35. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.
Lacal PM; Graziani G
Pharmacol Res; 2018 Oct; 136():97-107. PubMed ID: 30170190
[TBL] [Abstract][Full Text] [Related]
37. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model.
Du H; Li P; Pan Y; Li W; Hou J; Chen H; Wang J; Tang H
Brain Res; 2010 Oct; 1357():1-8. PubMed ID: 20637183
[TBL] [Abstract][Full Text] [Related]
39. Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells.
Yamagishi N; Teshima-Kondo S; Masuda K; Nishida K; Kuwano Y; Dang DT; Dang LH; Nikawa T; Rokutan K
BMC Cancer; 2013 May; 13():229. PubMed ID: 23651517
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic CD8
Pham TT; Verheijen M; Vandermosten L; Deroost K; Knoops S; Van den Eynde K; Boon L; Janse CJ; Opdenakker G; Van den Steen PE
Front Cell Infect Microbiol; 2017; 7():416. PubMed ID: 29034214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
